Aster Capital Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.29M Buy
+6,700
New +$722K 0.47% 35
2025
Q1
– Sell
-11,987
Closed -$498K – 1530
2024
Q4
$498K Buy
+11,987
New +$573K 0.19% 146

Other funds holding MRNA

Aster Capital Management's MRNA Position: Q3 2026 in Review

Aster Capital Management opened a new position in Moderna (MRNA) in Q3 2026: 6,700 shares worth $1.29M. The stake represents 0.47% of the portfolio and ranks #35 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in MRNA as recently as Q4 2024.

Aster Capital Management first reported a position in MRNA in Q4 2024 and has held it in 2 quarters since. 1,032 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Aster Capital Management held 6,700 shares of Moderna worth $1.29M as of Q3 2026.
  • Moderna was a new Aster Capital Management position in Q3 2026.
  • Moderna made up 0.47% of Aster Capital Management's portfolio in Q3 2026, its #35 holding.
  • Aster Capital Management first reported a position in Moderna in Q4 2024 and has held it in 2 quarters since.
  • 1,032 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.